Themis Medicare's promoter, Vividhmargi Trust, has pledged 40.96% of its stake, or 27.49% of total shares, for a ₹135 crore debt. Funds are for personal use, not company operations.
Themis Medicare Promoter Pledges Significant Stake
Promoter Vividhmargi Trust has pledged 2,53,17,620 shares of Themis Medicare, representing 27.49% of the company's total share capital.
Reader Takeaway: Promoter pledges for personal debt pose governance risk; transparency on unlisted debentures is limited.
What just happened
Vividhmargi Trust, the promoter of Themis Medicare Ltd, has created a new encumbrance on its shares. A total of 2,53,17,620 shares have been pledged, which amounts to 40.96% of the promoter's total holding and 27.49% of the company's overall share capital.
Why this matters
This pledge is to secure a debt instrument of ₹135 crore. The shares have been encumbered in favour of CTL Trusteeship Limited. Importantly, the filing indicates that the funds raised are for the personal use of the promoters and their PACs (Persons Acting in Concert), not for the benefit of Themis Medicare Limited.
The value of the pledged shares is ₹284.19 crore, providing a security cover of 1:2.10 against the ₹135 crore amount involved. The debt instrument is described as Unrated, Unlisted, Secured, Redeemable Non-Convertible Debentures.
The backstory
The promoter holding in Themis Medicare was 6,18,03,990 shares prior to this pledge. The encumbrance was created on June 29, 2026, with OSS Software Solutions Labs Private Limited listed as the borrower.
What changes now
With a substantial portion of the promoter's stake now pledged, it highlights a reliance on share-backed financing for liquidity. This could potentially increase stock volatility, especially under adverse market conditions.
Risks to watch
A key concern is the high percentage of promoter pledging (40.96% of their holding), signalling a significant dependence on shares for liquidity. Another point of concern is that the funds are designated for personal use by promoters, which does not directly benefit the listed entity. The use of unlisted and unrated debt instruments also presents a transparency challenge, as it limits public access to the specific terms and covenants of the borrowing.
Peer comparison
While specific promoter pledging percentages vary across the pharmaceutical sector, high levels of promoter pledging can be viewed cautiously by investors due to potential governance concerns and increased financial risk for the promoter entity.
Context metrics (time-bound)
- Date of Pledge Creation: June 29, 2026
- Total Promoter Holding: 6,18,03,990 shares
- Shares Pledged: 2,53,17,620 shares
- Encumbrance (% of Total Share Capital): 27.49%
- Encumbrance (% of Promoter Holding): 40.96%
- Value of Shares Pledged: ₹284.19 crore
- Amount Involved (Debt): ₹135 crore
What to track next
Investors should monitor any future announcements regarding the repayment of this debt, any changes in the promoter's holding, and the overall financial health of both the promoter group and Themis Medicare Limited. Transparency on the terms of the unlisted debentures will be crucial.